Rockwell Medical Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio0.650.640.160.621.52
P/B Ratio2.022.530.8415.202.77
Price/Tangible Book3.075.600.9023.872.84
Price/FCF20.66
Price/OCF15.69
Enterprise Value Ratios
EV/Revenue0.610.680.090.560.81
EV/EBITDA22.18
EV/EBIT101.70
EV/FCF19.38
Profitability & Returns
Return on Equity (ROE)-0.02%-0.48%-2.24%-1.78%-1.13%
Return on Assets (ROA)0.01%-0.08%-0.22%-0.30%-0.29%
Return on Capital Employed (ROCE)0.01%-0.19%-0.58%-1.10%-0.44%
Leverage & Solvency Ratios
Debt/Equity0.410.631.1611.400.70
Debt/EBITDA2.75
Debt/FCF4.24
Liquidity Ratios
Current Ratio2.631.732.001.685.43
Quick Ratio2.121.311.571.354.91
Efficiency Ratios
Asset Turnover1.821.691.530.981.02
Inventory Turnover14.4212.8213.9016.1115.73
Yield & Distribution Ratios
Earnings Yield-0.01%-0.16%-1.58%-0.85%-0.33%
FCF Yield0.05%-0.18%-1.46%-0.88%-0.32%
Buyback Yield-0.33%-0.63%-0.68%-0.24%-0.24%